Chronic treatment with a novel orally active non-selective endothelin receptor antagonist in heart failure

被引：0
|
作者：
Ohnishi, M [1 ]
Wada, A [1 ]
Tsutamoto, T [1 ]
Maeda, Y [1 ]
Fukai, D [1 ]
Sawaki, M [1 ]
Maeda, K [1 ]
Hisanaga, T [1 ]
Mabuchi, N [1 ]
Kinoshita, M [1 ]
机构：
[1] SHIGA UNIV MED SCI,OTSU,SHIGA 52021,JAPAN
来源：
CIRCULATION | 1997年 / 96卷 / 11期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：4292 / 4292
页数：1
相关论文
共 50 条
  • [1] Selective or non-selective endothelin receptor blockade in chronic heart failure?
    Love, MP
    Ferro, CJ
    Haynes, WG
    Webb, DJ
    McMurray, JJ
    CIRCULATION, 1996, 94 (08) : 425 - 425
  • [2] Chronic effects of an orally active selective endothelin-B-receptor antagonist in experimental congestive heart failure
    Sawaki, M
    Wada, A
    Tsutamoto, T
    Ohnishi, M
    Fujii, M
    Matsumoto, T
    Kinoshita, M
    JOURNAL OF CARDIOVASCULAR PHARMACOLOGY, 2000, 36 : S323 - S326
  • [3] Direct comparison of selective endothelin A and non-selective endothelin A/B receptor blockade in chronic heart failure
    Leslie, SJ
    Spratt, JCS
    McKee, SP
    Strachan, FE
    Newby, DE
    Northridge, DB
    Denvir, MA
    Webb, DJ
    HEART, 2005, 91 (07) : 914 - 919
  • [4] An orally active non-selective endothelin receptor antagonist, bosentan, markedly reduces injury in a rat model of colitis
    Hogaboam, CM
    Muller, MJ
    Collins, SM
    Hunt, RH
    EUROPEAN JOURNAL OF PHARMACOLOGY, 1996, 309 (03) : 261 - 269
  • [5] Chronic effects of a novel, orally active endothelin receptor antagonist, T-0201, in dogs with congestive heart failure
    Ohnishi, M
    Wada, A
    Tsutamoto, T
    Fukai, D
    Sawaki, M
    Maeda, Y
    Kinoshita, M
    JOURNAL OF CARDIOVASCULAR PHARMACOLOGY, 1998, 31 : S236 - S238
  • [6] Adverse hemodynamic effects of a selective endothelin ETB receptor antagonist in patients with chronic heart failure:: reversal with a selective endothelin ETA receptor antagonist
    Cowburn, PJ
    Cleland, JGF
    McDonagh, TA
    McArthur, JD
    MacLean, MR
    Dargie, HJ
    CIRCULATION, 1998, 98 (17) : 718 - 718
  • [7] Attenuation of ischemic liver injury by a non-selective endothelin receptor antagonist
    Jin, MB
    Zhu, Y
    Zhang, S
    Ishizaki, N
    Tanaka, H
    Subbotin, VM
    Lee, RG
    Starzl, TE
    Todo, S
    TRANSPLANTATION PROCEEDINGS, 1997, 29 (1-2) : 1335 - 1335
  • [8] Performance-enhancing effects of non-selective endothelin receptor antagonist
    Ostojic, Sergej M.
    Stojanovic, Marko
    Calleja-Gonzalez, Julio
    Olcina, Guillermo
    Sekulic, Damir
    Hoffman, Jay R.
    INTERNATIONAL JOURNAL OF CARDIOLOGY, 2014, 171 (02) : 294 - 297
  • [9] Clinical and hemodynamic effects of an orally active endothelin-1-receptor antagonist in patients with refractory chronic heart failure.
    Suetsch, G
    Christen, S
    Yan, XW
    Strobel, W
    Rickenbacher, P
    Hunziker, P
    Bertel, O
    Kiowski, W
    CIRCULATION, 1997, 96 (08) : 511 - 511
  • [10] Long-term treatment with the novel non-peptide endothelin receptor antagonist 0213 in rats with chronic heart failure
    Huang, M
    Qi, JS
    He, HJ
    Dai, DZ
    Ji, M
    DRUG DEVELOPMENT RESEARCH, 2002, 55 (04) : 266 - 267
12345